Publication
Find out more
Association Between Results of a…
Conventional staging methods are inadequate to identify patients with stage II colon cancer (CC)...
Publications
Publication
Find out more
Development and Independent Validation of…
Current prognostic factors are poor at identifying patients at risk of disease recurrence after...
Publication
Find out more
Identification and Validation of an…
There is no method routinely used to predict response to anthracycline and cyclophosphamide–based chemotherapy...
Publication
Find out more
Activation of STING-Dependent Innate Immune…
Background: Previously we identified a DNA damage response deficient (DDRD) molecular subtype within breast cancer....
Publication
Find out more
Validation of a Metastatic Assay…
Radiotherapy is an effective treatment of intermediate/high-risk locally advanced prostate cancer, however,>30% of patients...
Publication
Find out more
Molecular Subgroup of Primary Prostate…
Background: Approximately 4–25% of patients with early prostate cancer develop disease recurrence following radical...